What is the average shipment value for India to South Korea pharmaceutical trade?

$121.8K per consignment across 406 shipments.

How many Indian pharmaceutical companies export to South Korea?

61 Indian companies. Largest: SAMYANG HOLDINGS CORPORATION with $13.5M.

How can I find verified Indian pharmaceutical suppliers for South Korea?

TransData Nexus covers 61 active exporters with shipment history and trade values at transdatanexus.com.

South Korea to India Pharmaceutical Import (2026) — $49.5M, 61 Foreign Suppliers | TransData Nexus

South Korea to India Pharmaceutical Import (2026) — $49.5M, 61 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — South Korea to India

#	Formulation	Value	Share
1	Vaccine	$16.5M	33.4%
2	Paclitaxel	$13.5M	27.3%
3	Vitamin	$7.0M	14.1%
4	Potassium	$6.5M	13.2%
5	Immunoglobulin	$3.9M	7.8%
6	Sodium	$1.2M	2.3%
7	Amino	$197.9K	0.4%
8	Pemetrexed	$147.9K	0.3%
9	Pembrolizumab	$129.6K	0.3%
10	Carboplatin	$89.3K	0.2%
11	Collagen	$87.9K	0.2%
12	Plasma	$86.1K	0.2%
13	Protein	$67.5K	0.1%
14	Nicotine	$31.9K	0.1%
15	Rituximab	$28.6K	0.1%

India imports 20+ pharmaceutical formulations from South Korea with a combined trade value of $49.5M. Key products include Vaccine ($16.5M), Paclitaxel ($13.5M), Vitamin ($7.0M), Potassium ($6.5M), Immunoglobulin ($3.9M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 406 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — South Korea to India Trade Routes

1Vaccine$16.5M

2Paclitaxel$13.5M

3Vitamin$7.0M

4Potassium$6.5M

5Immunoglobulin$3.9M

6Sodium

Top South Korea Suppliers to India

1Samyang Holdings Corporation

$13.5M

2Ckd Bio Corporation

$6.5M

3Boditech Med Inc.

$2.8M

4Boditech Med Inc.,

$2.5M

5Choong Ang Vaccine Laboratories Co Ltd

$2.5M

Trade Statistics

Total Value$49.5M

Shipments406

Indian Exporters61

South Korea Buyers57

Avg Shipment$122K

Products34

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to South Korea?

India exported pharmaceuticals worth $49.5M to South Korea across 406 verified shipments.

Who are the top Indian pharmaceutical exporters to South Korea?

1. SAMYANG HOLDINGS CORPORATION — $13.5M. 2. CKD BIO CORPORATION — $6.5M. 3. BODITECH MED INC. — $2.8M. Total: 61 suppliers.

Which companies in South Korea import pharmaceuticals from India?

1. LUPIN LIMITED — $12.5M. 2. INTAS PHARMACEUTICALS LIMITED — $6.5M. 3. BHARAT SERUMS AND VACCINES LIMITED — $3.8M. 57 buyers total.

What pharmaceutical products does India export most to South Korea?

1. Vaccine ($16.5M, 33.4%); 2. Paclitaxel ($13.5M, 27.3%); 3. Vitamin ($7.0M, 14.1%); 4. Potassium ($6.5M, 13.2%); 5. Immunoglobulin ($3.9M, 7.8%)

Which ports handle pharmaceutical shipments from India to South Korea?

Export: . Import: .

Why does South Korea import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $49.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply South Korea?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to South Korea identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 406 verified shipments from 61 Indian exporters to 57 South Korea buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

61 Exporters

57 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

South Korea to India Pharmaceutical Import